← back to search

Toshimitsu Fujii

Tokyo Institute of Psychiatry · JP
Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Autoimmune and Inflammatory Disorders, and Gastrointestinal Bleeding Diagnosis and Treatment.
h-index
26
citations
2,657
works
176
NIH funding
primary concept
Medicine
email

Recent publications

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
The Lancet 2024cited by 75position: middledoi
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
Gastroenterology 2023cited by 90position: middledoi
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn’s Disease in a Randomized Phase 3 Trial
Journal of Crohn s and Colitis 2023cited by 14position: middledoi
Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes
Digestive Diseases and Sciences 2020cited by 36position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Brian G. Feagan · Western University1 papers (2023–2023)Jasmina Kalabic · AbbVie (Germany)1 papers (2023–2023)Taku Kobayashi · The University of Tokyo1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2020–2020)Atsushi Sakuraba · Rush University Medical Center1 papers (2020–2020) · 1 papers (2020–2020)Masakazu Nagahori · The Health Care Science Institute1 papers (2020–2020) · 1 papers (2020–2020)Joana Torres · University of Lisbon1 papers (2023–2023) · 1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2023–2023)Qian Cao · McGill University Health Centre1 papers (2023–2023) · 1 papers (2020–2020) · 1 papers (2020–2020)Sofie Berg · Nutrition-Génétique et Exposition aux Risques Environnementaux1 papers (2023–2023)Qing Zhou · AbbVie (United States)1 papers (2023–2023)Xiaomei Liao · Ta Solutions (China)1 papers (2023–2023) · 1 papers (2020–2020)